Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

This study has been completed.

Study NCT00228982 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: September 27, 2005 Last Updated: May 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2005
Estimated Primary Completion Date:	No date given